Heard on the street

Western frontrunners (such as Pfizer/BioNTech, AstraZeneca-Oxford and Moderna) have already completed phase three trails and publicly released data that has been reviewed by regulators in Europe, the UK and the United States

I started writing this column during the last financial crises in 2008 – so far, close to 250 columns! Published like clockwork; didn’t miss any: started with once every fortnight and lately, once a month. Each piece took-on an event, occurrence, issue of current public interest.

The columns were well received. Readers wanted more diversity – they hoped for views on wide-ranging political-economic issues that matter.